Summit Global Investments’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-8,044
| Closed | -$322K | – | 585 |
|
|
2023
Q2 | $322K | Buy |
+8,044
| New | +$322K | 0.02% | 410 |
|
|
2022
Q4 | – | Sell |
-20,900
| Closed | -$1.11M | – | 481 |
|
|
2022
Q3 | $1.11M | Buy |
20,900
+4,500
| +27% | +$239K | 0.1% | 190 |
|
|
2022
Q2 | $956K | Buy |
16,400
+1,300
| +9% | +$75.8K | 0.08% | 223 |
|
|
2022
Q1 | $1.15M | Sell |
15,100
-15,800
| -51% | -$1.21M | 0.08% | 216 |
|
|
2021
Q4 | $1.86M | Buy |
30,900
+12,800
| +71% | +$770K | 0.12% | 153 |
|
|
2021
Q3 | $1.01M | Buy |
+18,100
| New | +$1.01M | 0.08% | 197 |
|